Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May 17:19:675-682.
doi: 10.1016/j.nicl.2018.05.020. eCollection 2018.

Cortical markers of cognitive syndromes in amyotrophic lateral sclerosis

Affiliations

Cortical markers of cognitive syndromes in amyotrophic lateral sclerosis

Monica Consonni et al. Neuroimage Clin. .

Abstract

Amyotrophic lateral sclerosis (ALS) can be associated with a spectrum of cognitive and behavioural symptoms, but the related patterns of focal cortical atrophy in non-demented ALS patients remain largely unknown. We enrolled 48 non-demented ALS patients and 26 healthy controls for a comprehensive neuropsychological assessment and a magnetic resonance exam. Behavioural and cognitive impairment was defined on the basis of a data-driven multi-domain approach in 21 ALS patients. Averaged cortical thickness of 74 bilateral brain regions was used as a measure of cortical atrophy. Cortical thinning in a fronto-parietal network, suggesting a disease-specific pattern of neurodegeneration, was present in all patients, independent of cognitive and behavioural status. Between-group and correlational analyses revealed that inferior frontal, temporal, cingular and insular thinning are markers for cognitive and behavioural deficits, with language impairment mainly related to left temporal pole and insular involvement. These specific correlates support the concept of a spectrum of deficits, with an overlap between the ALS cognitive phenotypes and the syndromes of frontotemporal dementia.

Keywords: ALS, amyotrophic lateral sclerosis; ALSbi, ALS with mild behavioural impairment; ALSci, ALS with mild cognitive impairment; ALScn, cognitively-normal ALS; ALSimp, ALS with cognitive and/or behavioural impairment; Amyotrophic lateral sclerosis; C9+ ALS, ALS harbouring C9orf72 repeat expansion; C9– ALS, ALS without C9orf repeat expansion; CT, cortical thickness; Cognitive impairment; Cognitive profiles; Cortical thickness; FTD, frontotemporal dementia; GM, grey matter; HC, healthy control; MD, multi-domain; Temporal lobe.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Neuropsychological profiles of ALS patients according to the MD classification. ALScn = cognitively-normal ALS patients; ALSbi = ALS patients mild behavioural impairment; ALSciα = ALS patients with mild dysexecutive impairment (with ≥2 performances below cut-off on tests addressing executive cognitive functions); ALSciβ = ALS patients with ≥2 performances below cut-off on tests addressing non-executive cognitive functions (social cognition, language and memory); ALSciα + β = ALS patients with a mixed cognitive profile; ALSbi-ciβ = ALSbi patients with non-executive cognitive impairment; ALSbi-ciα + β = ALSbi patients with the ALSci α + β profile.
Fig. 2
Fig. 2
Distribution of the cortical thinning in patients with ALS considering their cognitive status. Yellow indicates thinning in ALSimp patients compared to HC volunteers; blue indicates thinning in ALScn patients compared to HC volunteers; green indicates overlap between these comparisons. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Fig. 3
Fig. 3
Distribution of the cortical thinning (in red) on the pial surface of the right hemisphere (lateral and inferior views) in ALSimp patients compared to ALScn patients. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

Similar articles

Cited by

References

    1. Abdulla S., Machts J., Kaufmann J., Patrick K., Kollewe K., Dengler R., Heinze H.J., Petri S., Vielhaber S., Nestor P.J.L. Hippocampal degeneration in patients with amyotrophic lateral sclerosis. Neurobiol. Aging. 2014;35:2639–2645. - PubMed
    1. Agosta F., Valsasina P., Riva N., Copetti M., Messina M.J., Prelle A., Comi G., Filippi M. The cortical signature of amyotrophic lateral sclerosis. PLoS One. 2012;7 - PMC - PubMed
    1. Agosta F., Canu E., Valsasina P., Riva N., Prelle A., Comi G., Filippi M. Divergent brain network connectivity in amyotrophic lateral sclerosis. Neurobiol. Aging. 2013;34:419–427. - PubMed
    1. Agosta F., Ferraro P.M., Riva N., Spinelli E.G., Chiò A., Canu E., Valsasina P., Lunetta C., Iannaccone S., Copetti M., Prudente E., Comi G., Falini A., Filippi M. Structural brain correlates of cognitive and behavioral impairment in MND. Hum. Brain Mapp. 2016;37:1614–1626. - PMC - PubMed
    1. Ash S., Olm C., McMillan C.T., Boller A., Irwin D.J., McCluskey L., Elman L., Grossman M. Deficits in sentence expression in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Frontotemporal. Degener. 2015;16:31–39. - PMC - PubMed

Publication types